Loading...
Loading...
Browse all stories on DeepNewz
VisitWhich health condition will AI target next in the UK after Find-AF by 2025?
Diabetes • 25%
Hypertension • 25%
Chronic Obstructive Pulmonary Disease (COPD) • 25%
Cancer • 25%
Announcements from the NHS or British Heart Foundation on new AI initiatives
UK's Find-AF Trial Uses AI to Detect Atrial Fibrillation Early
Dec 28, 2024, 11:23 AM
A new artificial intelligence tool is being trialed in the UK to detect atrial fibrillation (AF), a heart condition that can lead to strokes, before symptoms appear. The tool, developed by scientists and clinicians at the University of Leeds and Leeds Teaching Hospitals NHS Trust, analyzes GP records for 'red flags' that indicate a risk of developing AF. The trial, named Find-AF, is funded by the British Heart Foundation (BHF) and Leeds Hospitals Charity. It uses anonymized electronic health records from over 2.1 million people to train the algorithm, which has been validated with data from an additional 10 million records. The tool assesses risk based on factors including age, sex, ethnicity, and other medical conditions. High-risk individuals are offered a handheld electrocardiography (ECG) machine for further monitoring. John Pengelly, a retired Army captain from West Yorkshire, participated in the trial and was diagnosed with AF, which he now manages with medication to reduce his stroke risk. If successful, the trial could lead to a nationwide rollout, potentially preventing thousands of strokes annually, as AF is a contributing factor in around 20,000 strokes each year in the UK.
View original story
Yes • 50%
No • 50%
Unsuccessful • 25%
Moderately successful • 25%
Highly successful • 25%
Neutral • 25%
51-100 hospitals • 25%
0-50 hospitals • 25%
More than 150 hospitals • 25%
101-150 hospitals • 25%
USA • 25%
UK • 25%
Germany • 25%
Other • 25%
Canada • 25%
United Kingdom • 25%
Australia • 25%
United States • 25%
Time Saving • 25%
Cost Efficiency • 25%
Patient Demand • 25%
Accuracy Improvement • 25%
Yes • 50%
No • 50%
Cancer • 25%
Neurological disorders • 25%
Infectious diseases • 25%
Other • 25%
No significant benefit • 25%
Early detection of atrial fibrillation • 25%
Reduced stroke risk • 25%
Improved treatment outcomes • 25%
Kaiser Permanente • 25%
None of these • 25%
Cleveland Clinic • 25%
Mayo Clinic • 25%
21-30% reduction • 25%
More than 30% reduction • 25%
Less than 10% reduction • 25%
10-20% reduction • 25%